Generic Zelapar

At this time, no generic Zelapar (orally disintegrating selegiline) products are available in the United States. Companies on the Internet may claim to sell a generic version of the drug, but these drugs could be fake, substandard, and potentially dangerous. You should not buy any generic Zelapar until an approved version is available, which is predicted to be in July 2014, when the first patent expires.

Zelapar Drug Information

Generic Zelapar: An Overview

Zelapar^® (orally disintegrating selegiline) is a prescription Parkinson's disease medication. It belongs to a group of medications known as monoamine oxidase inhibitors (MAOIs). It is only approved for use in combination with carbidopa-levodopa medications, such as Sinemet^®, Sinemet^® CR, or Parcopa^®.

Zelapar is made by Valeant Pharmaceuticals. It is currently under the protection of a patent that prevents any generic Zelapar from being manufactured or sold in the United States. However, if you search the Internet for "generic Zelapar," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Zelapar may be available from another country, but there is no way of knowing if you are getting genuine Zelapar or not. You should not buy any generic Zelapar until an approved generic version is available.

When Will Generic Zelapar Be Available?

The first patent for Zelapar currently expires in July 2014. This is the earliest predictable date that a generic version of the drug could become available. However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Zelapar uses. Once the patent expires, several companies likely will begin manufacturing a generic Zelapar drug.

(Generic Zelapar Continued: Page 2)